Table 3.
No. | Nodules location | Nature | Surgical type | Duration of one-stage VATS (min) | Blood loss (ml) | Pathological results |
---|---|---|---|---|---|---|
1 | RU/RL/RL | GGO/Solid/Solid | Wedge/Wedge/Wedge | 170 | 100 | Benign/Benign/Benign |
2 | LL/RM/RL | GGO/mGGO/mGGO | Wedge/Wedge/Wedge | 180 | 100 | Benign/Benign/Benign |
3 | RU /RM | Solid/Solid | Wedge/Wedge | 205 | 100 | PC/PC |
4 | RU /RL | GGO/GGO | Wedge/Wedge | 60 | 50 | AIS/PC |
5 | RU /LU | GGO/GGO | Wedge/Wedge | 90 | 50 | PC/PC |
6 | RU /RL | mGGO/mGGO | Wedge+ lobectomy/Wedge | 230 | 50 | IA/MIA |
7 | LL/RU | Solid/GGO | Wedge/Wedge | 130 | 100 | Benign/PC |
8 | RM/RL | GGO/GGO | Wedge/Wedge | 70 | 50 | PC/PC |
9 | LL/ LL | GGO/GGO | Wedge/Wedgea | 360 | 200 | AIS/AIS |
10 | RL/RU | Solid /mGGO | Wedge/Wedge | 145 | 100 | Benign/PC |
11 | LL/RM | Solid/Solid | Wedge/Wedge | 200 | 200 | Benign/Benign |
12 | RL/RM | GGO/Solid | Wedge/Wedgea | 195 | 100 | Benign/MIA |
13 | RU/RU/RU | GGO/GGO/GGO | Wedge/Wedge/Wedgea | 310 | 200 | Benign/PC/MIA |
14 | LU/ LL | GGO/GGO | Wedge/Wedge | 80 | 10 | AIS/PC |
15 | LU/ LU | GGO/Solid | Wedge/Wedge | 100 | 50 | AIS/Metastasis |
16 | LL/LU | Solid/Solid | Wedge/Wedgeb | 165 | 150 | Benign/PC |
17 | LU/ LL | GGO/Solid | Wedge/Wedge | 80 | 60 | AIS/IA |
18 | LU/ LL | Solid/Solid | Wedge/Wedge | 270 | 20 | Benign/Benign |
19 | RL/RL/RM/RU | GGO/GGO/GGO/mGGO | Wedge/Wedge/Wedge/Wedge | 225 | 100 | AIS/AIS/Benign/AIS |
VATS video-assisted thoracoscopic surgery, RU right upper, RM right middle, RL right lower, LU left upper, LL left lower, GGO ground-glass opacity, mGGO mixed GGO, PC precancerosis, AIS adenocarcinoma in situ, MIA minimally invasive adenocarcinoma, IA invasive adenocarcinoma. a: These patients had synchronous definite diagnosed lung cancer and they underwent lobectomy and wedge resection during a single-stage VATS procedure. b: This wedge resection was performed based on the palpation of the coil